Rejection of bone marrow cell allografts by natural killer cell subsets: 5E6+ cell specificity for Hh‐1 determinant 2 shared by H‐2d and H‐2f
- 1 November 1991
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 21 (11), 2821-2828
- https://doi.org/10.1002/eji.1830211125
Abstract
The 5E6 antigen, defined by anti‐5E6 mAb, is expressed on one‐half of murine natural killer (NK) cells, and we have previously demonstrated (C. L. Sentman et al., J. Exp. Med. 1989. 170: 1991) that 5E6+ NK cells are necessary for the rejection of BALB/c (Hh‐1d) but not C567BL/6 (Hh‐1b) bone marrow cells (BMC). In experiments described here, we have characterized the specificity of 5E6+ and 5E6− NK cell subsets for hemopoietic histocompatibility‐1 (Hh‐1) antigens. Prospective recipient mice were treated with anti‐5E6 mAb and challenged with BMC from a variety of donors. In addition, H‐2d/Hh‐1d C.B‐17 scid 5E6+ or 5E6− NK cells were adoptively transferred into irradiated, NK cell‐depleted hosts and challenged with H‐2b/Hh‐1b BMC. The data indicate that the 5E6+ NK cells are necessary for the rejection of only those BMC that express the Hh‐1 determinant 2 shared by H‐2d and H‐2f haplotypes of strains BALB/c (d), A.Ca (f), and B10.M (f). No reactivity to other Hh‐1 antigens resides in the 5E6+ population. In contrast, the ability of NK cells to lyse H‐2d or H‐2b tumor cells was independent of 5E6 expression. These results suggest that the 5E6 molecule is likely to be important in the specific recognition and rejection of BMC that express Hh‐1 determinant 2, and is probably not involved in recognition of „tumor target cell structures”︁.Keywords
This publication has 29 references indexed in Scilit:
- Identification of four subsets of human CD3-CD16+ natural killer (NK) cells by the expression of clonally distributed functional surface molecules: correlation between subset assignment of NK clones and ability to mediate specific alloantigen recognition.The Journal of Experimental Medicine, 1990
- A novel surface antigen expressed by a subset of human CD3- CD16+ natural killer cells. Role in cell activation and regulation of cytolytic function.The Journal of Experimental Medicine, 1990
- In search of the ‘missing self’: MHC molecules and NK cell recognitionImmunology Today, 1990
- Identification of a subset of murine natural killer cells that mediates rejection of Hh-1d but not Hh-1b bone marrow grafts.The Journal of Experimental Medicine, 1989
- Severe Herpesvirus Infections in an Adolescent without Natural Killer CellsNew England Journal of Medicine, 1989
- Specific lysis of allogeneic cells after activation of CD3- lymphocytes in mixed lymphocyte culture.The Journal of Experimental Medicine, 1988
- Selective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategyNature, 1986
- Host resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanism.The Journal of Experimental Medicine, 1985
- Natural resistance of lethally irradiated F1 hybrid mice to parental marrow grafts is a function of H-2/Hh-restricted effectors.The Journal of Experimental Medicine, 1984
- GENETIC CONTROL OF BONE MARROW GRAFT REJECTIONThe Journal of Experimental Medicine, 1971